Terazosin Hydrochloride

Product NDC: 0781-2054
11-digit product format: 007812054
Labeler code: 0781
Product ID: 0781-2054_7d3db2e2-2f65-45df-9259-2b8e54eddb87
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Terazosin Hydrochloride
Dosage form: CAPSULE
Route: ORAL
Labeler: Sandoz Inc
Application: ANDA074823
Marketing category: ANDA
Marketing start: 1998-03-30
Marketing end: 2021-08-31
Substance: TERAZOSIN HYDROCHLORIDE
Active strength: 10 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0781-2054		D	Discontinued by firm	2026-08-11
excluded package	package	0781-2054	0781-2054-01	D	Discontinued by firm	2026-08-11
excluded package	package	0781-2054	0781-2054-05	D	Discontinued by firm	2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0781-2054-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0781-2054-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0781-2054-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0781-2054-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0781-2054-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0781-2054-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0781-2054-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0781-2054-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0781-2054-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0781-2054-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0781-2054-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0781-2054-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0781-2054-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0781-2054-05	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0781-2054-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0781-2054-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0781-2054-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0781-2054-05	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0781-2054-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0781-2054-05	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0781-2054-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0781-2054-05	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0781-2054-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0781-2054-05	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A074823-001	TERAZOSIN HYDROCHLORIDE	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1998-03-30
A074823-002	TERAZOSIN HYDROCHLORIDE	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1998-03-30
A074823-003	TERAZOSIN HYDROCHLORIDE	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1998-03-30
A074823-004	TERAZOSIN HYDROCHLORIDE	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	1998-03-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A074823-001	AB
A074823-002	AB
A074823-003	AB
A074823-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A074823-001	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1998-03-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074823-002	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1998-03-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074823-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1998-03-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074823-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	1998-03-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074823-001	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1998-03-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074823-002	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1998-03-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074823-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1998-03-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074823-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	1998-03-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074823-001	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1998-03-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074823-002	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1998-03-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074823-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1998-03-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074823-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	1998-03-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074823-001	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1998-03-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074823-002	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1998-03-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074823-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1998-03-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074823-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	1998-03-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074823-001	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1998-03-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074823-002	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1998-03-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074823-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1998-03-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074823-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	1998-03-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074823-001	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1998-03-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074823-002	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1998-03-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074823-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1998-03-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074823-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	1998-03-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074823-001	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1998-03-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074823-002	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1998-03-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074823-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1998-03-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074823-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	1998-03-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074823-001	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1998-03-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074823-002	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1998-03-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074823-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1998-03-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074823-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	1998-03-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074823-001	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1998-03-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074823-002	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1998-03-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074823-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1998-03-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074823-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	1998-03-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074823-001	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1998-03-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074823-002	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1998-03-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074823-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1998-03-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074823-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	1998-03-30	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A074823-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074823-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074823-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074823-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074823-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074823-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074823-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074823-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074823-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074823-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074823-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074823-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074823-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074823-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074823-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074823-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074823-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074823-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074823-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074823-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074823-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074823-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074823-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074823-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074823-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074823-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074823-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074823-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074823-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074823-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074823-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074823-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074823-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074823-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074823-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074823-004	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074823-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074823-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074823-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074823-004	AB	1	`d06236e962d9…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
975cd6e7-95ee-60f8-7c38-135ffbb09240	Product name	2	20260223
1bc6d1ac-ef0f-4fc6-8704-c443f03b274a	Product name	1	20250311
8adc9826-3fee-6091-f1ee-af9fd6f9caf8	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0781-2054-01	EA - Each	0781-2054	7c636fd0-33de-41dc-9fdf-26e02f1ef1a1	1	2012-07-24
0781-2054-05	EA - Each	0781-2054	f005be0d-8f9e-4fd9-8df0-ab2d9ba6b9a6	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
TERAZOSIN HYDROCHLORIDE	ACTIVE INGREDIENT	D32S14F082	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
TERAZOSIN	ACTIVE MOIETY	8L5014XET7	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
GELATIN	INACTIVE INGREDIENT	2G86QN327L	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
SHELLAC	INACTIVE INGREDIENT	46N107B71O	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	TERAZOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]	13
TERAZOSIN HYDROCHLORIDE	ACTIVE INGREDIENT	D32S14F082	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
TERAZOSIN	ACTIVE MOIETY	8L5014XET7	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
GELATIN	INACTIVE INGREDIENT	2G86QN327L	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
SHELLAC	INACTIVE INGREDIENT	46N107B71O	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	TERAZOSIN HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.]	6

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Terazosin Hydrochloride	TERAZOSIN HYDROCHLORIDE	Amerisyn, LLC	5680d373-0f61-baf8-e063-6394a90ab8a6	2026-07-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074823 application number: ANDA074823
Terazosin Hydrochloride	TERAZOSIN HYDROCHLORIDE	Amici Pharma, Inc.	4007dbd3-e850-43e7-8a56-8735e31063cd	2026-05-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074823 application number: ANDA074823
Terazosin Hydrochloride	TERAZOSIN HYDROCHLORIDE	Aphena Pharma Solutions - Tennessee, LLC	214d9b06-8d23-3ee8-e063-6394a90a1521	2024-09-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074823 application number: ANDA074823
Terazosin Hydrochloride	TERAZOSIN HYDROCHLORIDE	Aphena Pharma Solutions - Tennessee, LLC	9199083d-403f-4c9e-90e1-713ed0a07903	2023-04-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074823 application number: ANDA074823
Terazosin Hydrochloride	TERAZOSIN HYDROCHLORIDE	Aphena Pharma Solutions - Tennessee, LLC	e5507ea6-bdb3-4363-a68b-0478cbb25f4a	2021-08-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074823 application number: ANDA074823

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
D32S14F082	TERAZOSIN HYDROCHLORIDE	70024-40-7	TERAZOSIN HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
260376	terazosin HCl 10 MG Oral Capsule	PSN	40369190-10a4-4af5-a5f2-ed38562b443c	23
313219	terazosin HCl 5 MG Oral Capsule	PSN	40369190-10a4-4af5-a5f2-ed38562b443c	23
260376	terazosin 10 MG Oral Capsule	SCD	40369190-10a4-4af5-a5f2-ed38562b443c	23
313219	terazosin 5 MG Oral Capsule	SCD	40369190-10a4-4af5-a5f2-ed38562b443c	23
260376	terazosin (as terazosin HCl) 10 MG Oral Capsule	SY	40369190-10a4-4af5-a5f2-ed38562b443c	23
313219	terazosin (as terazosin hydrochloride) 5 MG Oral Capsule	SY	40369190-10a4-4af5-a5f2-ed38562b443c	23
313215	terazosin HCl 1 MG Oral Capsule	PSN	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6
260376	terazosin HCl 10 MG Oral Capsule	PSN	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6
313217	terazosin HCl 2 MG Oral Capsule	PSN	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6
313219	terazosin HCl 5 MG Oral Capsule	PSN	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6
313215	terazosin 1 MG Oral Capsule	SCD	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6
260376	terazosin 10 MG Oral Capsule	SCD	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6
313217	terazosin 2 MG Oral Capsule	SCD	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6
313219	terazosin 5 MG Oral Capsule	SCD	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6
313215	terazosin (as terazosin HCl) 1 MG Oral Capsule	SY	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6
260376	terazosin (as terazosin HCl) 10 MG Oral Capsule	SY	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6
313217	terazosin (as terazosin HCl) 2 MG Oral Capsule	SY	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6
313219	terazosin (as terazosin hydrochloride) 5 MG Oral Capsule	SY	88ac2dc1-062f-42c4-93ba-8a09116dbaed	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0781-2054-01	00781205401	100 CAPSULE in 1 BOTTLE (0781-2054-01)	100 capsule	1998-03-30	2021-07-31	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Terazosin Capsules, USP	A-S Medication Solutions	2020-02-19	HUMAN PRESCRIPTION DRUG LABEL	23
Terazosin Capsules, USP	Sandoz Inc	2019-02-28	HUMAN PRESCRIPTION DRUG LABEL	15
Terazosin Hydrochloride Capsules	Physicians Total Care, Inc.	2013-02-25	HUMAN PRESCRIPTION DRUG LABEL	6